Keros Therapeutics, Inc. (KROS)
10.00
-0.30
(-2.86%)
USD |
NASDAQ |
Jun 08, 16:00
10.09
+0.08
(+0.85%)
After-Hours: 19:08
Keros Therapeutics Max Drawdown (5Y) : 88.46% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| PTC Therapeutics, Inc. | 73.78% |
| Insmed, Inc. | 63.30% |
| United Therapeutics Corp. | 33.00% |
| Enanta Pharmaceuticals, Inc. | 95.62% |
| ACADIA Pharmaceuticals, Inc. | 77.18% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -40.59 |
| Beta (5Y) | 0.9403 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 70.47% |
| Historical Sharpe Ratio (5Y) | -0.4343 |
| Historical Sortino (5Y) | -0.627 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.29% |